| Literature DB >> 33673403 |
Ivana Dabaj1, Bénédicte Sudrié-Arnaud2, François Lecoquierre3, Kimiyo Raymond4, Franklin Ducatez1, Anne-Marie Guerrot3, Sarah Snanoudj2, Sophie Coutant3, Pascale Saugier-Veber3, Stéphane Marret1, Gaël Nicolas3, Abdellah Tebani2, Soumeya Bekri2.
Abstract
NGLY1 deficiency is the first recognized autosomal recessive disorder of N-linked deglycosylation (NGLY1-CDDG). This severe multisystemic disease is still poorly known and, to date, most cases have been diagnosed through whole exome or genome sequencing. The aim of this study is to provide the clinical, biochemical and molecular description of the first NGLY1-CDDG patient from France along with a literature review. The index case presented with developmental delay, acquired microcephaly, hypotonia, alacrimia, feeding difficulty, and dysmorphic features. Given the complex clinical picture and the multisystemic involvement, a trio-based exome sequencing was conducted and urine oligosaccharides were assessed using mass spectrometry. The exome sequencing revealed a novel variant in the NGLY1 gene in a homozygous state. NGLY1 deficiency was confirmed by the identification of the Neu5Ac1Hex1GlcNAc1-Asn oligosaccharide in the urine of the patient. Literature review revealed the association of some key clinical and biological features such as global developmental delay-hypertransaminasemia, movement disorders, feeding difficulties and alacrima/hypolacrima.Entities:
Keywords: NGLY1; NGLY1-CDDG; alacrimia; congenital disorder of deglycosylation; developmental delay; elevated transaminases; hypolacrimia; hypotonia; movement disorder
Year: 2021 PMID: 33673403 PMCID: PMC7996810 DOI: 10.3390/life11030187
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729